دورية أكاديمية

Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke.

التفاصيل البيبلوغرافية
العنوان: Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke.
المؤلفون: Wang, Liu ‐ Qing, Lin, Zhen ‐ Zhen, Zhang, Hong ‐ Xia, Shao, Bei, Xiao, Li, Jiang, Hui ‐ Gang, Zhuge, Qi ‐ Chuan, Xie, Luo ‐ Kun, Wang, Brian, Su, Dong ‐ Ming, Jin, Kun ‐ Lin
المصدر: CNS Neuroscience & Therapeutics; Apr2014, Vol. 20 Issue 4, p317-326, 10p
مصطلحات موضوعية: MESENCHYMAL stem cells, STEM cell transplantation, NEUROLOGICAL disorders, INFLAMMATION, ISCHEMIA, STROKE, HEALTH outcome assessment
مستخلص: Aims Intravenous transplantation of bone marrow mesenchymal stem cells ( BMSCs) had been documented to improve functional outcome after ischemic stroke. However, the timing and appropriate cell number of transplantation to achieve better outcome after an episode of stroke remain further to be optimized. Methods To determine the optimal conditions, we transplanted different concentrations of BMSCs at different time points in a rat model of ischemic stroke. Infarction volume and neurological behavioral tests were performed after ischemia. Results We found that transplantation of BMSCs at 3 and 24 h, but not 7 days after focal ischemia, significantly reduced the lesion volume and improved motor deficits. We also found that transplanted cells at 1 × 106 to 107, but not at 1 × 104 to 105, significantly improved functional outcome after stroke. In addition to inhibiting macrophages/microglia activation in the ischemic brain, BMSC transplantation profoundly reduced infiltration of gamma delta T ( γδT) cells, which are detrimental to the ischemic brain, and significantly increased regulatory T cells (Tregs), along with altered Treg-associated cytokines in the ischemic brain. Conclusions Our data suggest that timing and cell dose of transplantation determine the therapeutic effects after focal ischemia by modulating poststroke neuroinflammation. [ABSTRACT FROM AUTHOR]
Copyright of CNS Neuroscience & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17555930
DOI:10.1111/cns.12216